| | Volume 43,Issue 5,2024 Table of ContentsDownload Contents
Scientific Research on Drug Regulation Experimental Research | | | Mechanism of total flavones from lychee seed against liver fibrosis in rats by inhibiting TLR4-TAK1 | | | QIN Tiantian1, HUANG Panling2, HU Xinglan1, LUO Weisheng1, LI Yuqing1,3 | | | Published May 25, 2024 | | | 2024,43(5):417-421 [Abstract(2838)] [View PDF 1.89 M (3177)] | | | | | Research on the suppressive effects of alkaloids of bile-processed Gelsemium elegans on colon cancer cell proliferation | | | WANG Wenyi1, TAN Xinghui2, CHEN Nijishi2, LI Desen2, WU Shuisheng2 | | | Published May 25, 2024 | | | 2024,43(5):422-427 [Abstract(2872)] [View PDF 3.33 M (3228)] | | | | | Prediction and validation of potential targets for Alzheimer's disease treatment using ferulic acid | | | CHEN Siliang1, LIU Mengge1, SHI Jinning1, XU Xiaoqing1, CAI Hongyan2, HAN Weina1 | | | Published May 25, 2024 | | | 2024,43(5):428-434 [Abstract(2942)] [View PDF 3.44 M (3305)] | | | | | Synthesis and anti-breast cancer activity of phthalimide derivatives of genistein | | | ZHENG Xing1, KONG Linjun1, ZHU Yingli2,3, YAO Xu2 | | | Published May 25, 2024 | | | 2024,43(5):435-438,454 [Abstract(2692)] [View PDF 2.16 M (3437)] | | | | | Determination of Pamiparib in plasma of cancer patients by LC-MS / MS method | | | CHEN Shixian1, LIANG Xiaoxiao1, SHI Haiyan2, ZHANG Pei3, LIN Xiaoqing2, HUANG Xin1,2,3 | | | Published May 25, 2024 | | | 2024,43(5):439-443 [Abstract(3040)] [View PDF 1.29 M (2922)] | | | | | Optimization of the production process of Citicoline Sodium Injection based on QbD | | | HUANG Cuiping, WANG Yuqing, ZHANG Na | | | Published May 25, 2024 | | | 2024,43(5):444-448,486 [Abstract(3110)] [View PDF 1.15 M (2793)] | | | |
Review | | | Research progress on the effects and novel drug delivery strategies of curcumin in cardiovascular diseases | | | HAN Tuo1, YAN Bao'e2, ZHANG Jingruo1, LI Wen1, ZHANG Yan1 | | | Published May 25, 2024 | | | 2024,43(5):461-465,494 [Abstract(3113)] [View PDF 1.19 M (2865)] | | | | | The application of FGFR inhibitors in prostate cancer | | | GAO Yunxiang1, FAN Yiwei2, ZHU Yu2, ZHAO Chengguang2, ZHAO Haiyang1 | | | Published May 25, 2024 | | | 2024,43(5):466-472,479 [Abstract(2758)] [View PDF 2.00 M (3112)] | | | | | Research progress on anti-inflammatory effect and mechanism of Ginkgo biloba extract | | | XIA Jiang1, JIANG Jingjing1, WANG Xiaoling2, CHEN Jingfang2, YAN Hong2, ZHANG Wenjun1 | | | Published May 25, 2024 | | | 2024,43(5):473-479 [Abstract(3106)] [View PDF 2.72 M (3630)] | | | | | Tibetan medicine and research status in the treatment of hyperlipidemia | | | HE Changting1,2, CAI Zengzhuoma1,2, ZHANG Shoude1, QIE Yangrangzhong1 | | | Published May 25, 2024 | | | 2024,43(5):480-486 [Abstract(3054)] [View PDF 1.17 M (2806)] | | | | | Research Status of New lipid-lowering Drugs PCSK9 Inhibitors in Arteriosclerosis Cardiovascular Disease | | | ME Guowen1,2, LIU Shichang3, WANG Hailiang2, JIANG Wenyan1, WANG Xuejian1 | | | Published May 25, 2024 | | | 2024,43(5):487-494 [Abstract(2912)] [View PDF 1.20 M (2795)] | | | |
Clinical Pharmacy | | | CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants: interpretation of the 2023 CPIC guideline | | | ZHOU Changkai, YU Hongxia, CAO Mingchen, SHI Yunyan, LIU Donghua, JI Hongyan, XING Xiaomin, WANG Xinyi, LI Jing, JING Fanbo | | | Published May 25, 2024 | | | 2024,43(5):495-503 [Abstract(2989)] [View PDF 1.18 M (2725)] | | | | | Efficacy and safety of infliximab in the treatment of ulcerative colitis in children | | | ZHU Liping1, WEI Xuxia1, HAO Lina1, XUE Ning1, LI Xia2 | | | Published May 25, 2024 | | | 2024,43(5):504-508 [Abstract(2908)] [View PDF 1.12 M (2676)] | | | |
Pharmaceutical Education Pharmaceutical Management | | | Some considerations on the study of fat emulsion /amino acids /glucose injection | | | ZHANG Xin, WANG Hongliang, WU Xiaofei, XU Zhenyu | | | Published May 25, 2024 | | | 2024,43(5):513-515,520 [Abstract(3302)] [View PDF 1.12 M (2807)] | | | | | Problems analysis and policy interpretation of changes to batch for chemical drug under the new regulations | | | ZHOU Chong1, LIU Juntian1, XIE Jizhen1, XU Xiaojuan1, WU Haijun1, MA Chao2 | | | Published May 25, 2024 | | | 2024,43(5):516-520 [Abstract(2790)] [View PDF 1.11 M (2690)] | | | |
News in Brief
|